Goldman Sachs Initiates Coverage on Praxis Precision Medicines, Inc. (PRAX) with Buy
Rating Change Goldman Sachs analysts initiated coverage on Praxis Precision Medicines, Inc. (NASDAQ:PRAX) with a Buy rating on July 13, 2026. Market Context Praxis Precision…
Read more
